Therefore, the objective of this project was to determine the molecular mechanisms underlying the anticancer effect of glipizide and its synergistic outcome of glipizide combined with TRAIL in lung adenocarcinoma cells. The gene discussed is TNFSF10; the disease is lung adenocarcinoma.